| Primary |
| Rheumatoid Arthritis |
18.8% |
| Diabetes Mellitus |
12.5% |
| Metabolic Disorder |
12.5% |
| Oedema |
12.5% |
| Type 2 Diabetes Mellitus |
12.5% |
| Essential Hypertension |
6.3% |
| Fibromyalgia |
6.3% |
| Gout |
6.3% |
| Oesophageal Disorder |
6.3% |
| Osteoarthritis |
6.3% |
|
| Vomiting |
50.0% |
| Pancreatitis |
25.0% |
| Renal Impairment |
25.0% |
|
| Secondary |
| Diabetes Mellitus |
28.2% |
| Product Used For Unknown Indication |
23.1% |
| Ill-defined Disorder |
15.4% |
| Atrial Fibrillation |
7.7% |
| Essential Hypertension |
7.7% |
| Oedema |
5.1% |
| Gout |
2.6% |
| Metabolic Disorder |
2.6% |
| Oesophageal Disorder |
2.6% |
| Osteoarthritis |
2.6% |
| Schizoaffective Disorder |
2.6% |
|
| Vomiting |
23.1% |
| Hepatic Cancer |
15.4% |
| Myocardial Infarction |
15.4% |
| Pancreatitis Acute |
15.4% |
| Renal Failure |
15.4% |
| Multiple Gated Acquisition Scan Abnormal |
7.7% |
| Renal Impairment |
7.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.8% |
| Diabetes Mellitus |
18.5% |
| Type 2 Diabetes Mellitus |
8.1% |
| Hypertension |
5.9% |
| Colorectal Cancer Metastatic |
5.6% |
| Atrial Fibrillation |
3.6% |
| Breast Cancer Metastatic |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Schizophrenia |
1.7% |
| Sensory Disturbance |
1.7% |
| Cough |
1.4% |
| Depression |
1.4% |
| Her-2 Positive Breast Cancer |
1.4% |
| Osteoarthritis |
1.4% |
| Prophylaxis |
1.4% |
| Psoriasis |
1.4% |
| Pyrexia |
1.4% |
| Arthritis |
1.1% |
| Ascites |
1.1% |
|
| Weight Increased |
13.3% |
| Cerebrovascular Accident |
8.3% |
| Myocardial Infarction |
6.7% |
| Pneumonia |
6.7% |
| Pulmonary Oedema |
6.7% |
| Haemoglobin Decreased |
5.0% |
| Nausea |
5.0% |
| Transient Ischaemic Attack |
5.0% |
| Vomiting |
5.0% |
| Weight Decreased |
5.0% |
| Blood Glucose Increased |
3.3% |
| Central Pontine Myelinolysis |
3.3% |
| Death |
3.3% |
| Deep Vein Thrombosis |
3.3% |
| Dyspnoea |
3.3% |
| Fall |
3.3% |
| Haemorrhagic Stroke |
3.3% |
| Hypoglycaemia |
3.3% |
| Inappropriate Schedule Of Drug Administration |
3.3% |
| Myalgia |
3.3% |
|
